SCHEMBL2912012

SCHEMBL2912012

CC(C)(C)OC(=O)c1cn(CCCNc2ccc([N+](=O)[O-])c(N)n2)cc1-c1ccc(-n2ccnc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 2/20 0.41
GSK3B P49841 2/20 0.41
CDK1 P06493 1/20 0.41
BRD4 O60885 1/20 0.35
L3MBTL1 Q9Y468 3/20 0.34
CYP19A1 P11511 1/20 0.34
MAPT P10636 3/20 0.33
HTT P42858 2/20 0.33
PIK3CD O00329 1/20 0.32
ALDH1A1 P00352 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
MAPK1 P28482 1/20 0.32
ADH5 P11766 1/20 0.31
MAP3K5 Q99683 1/20 0.31
GPR119 Q8TDV5 1/20 0.31
DRD2 P14416 1/20 0.31
DRD3 P35462 1/20 0.31
NAMPT P43490 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2909662 0.90 GSK3A (0.44) GSK3AGSK3BCDK1L3MBTL1CYP19A1
SCHEMBL2904943 0.87 GSK3B (0.35) GSK3AGSK3BCDK1MAPTALDH1A1
SCHEMBL2911937 0.87 CDK1 (0.42) GSK3AGSK3BCDK1L3MBTL1CYP19A1
SCHEMBL2912739 0.87 CDK1 (0.40) GSK3AGSK3BCDK1L3MBTL1CYP19A1
SCHEMBL2904020 0.86 CDK1 (0.41) GSK3AGSK3BCDK1L3MBTL1CYP19A1
SCHEMBL2910908 0.86 GSK3B (0.41) GSK3AGSK3BCDK1MAPTHTT
SCHEMBL2914083 0.86 MET (0.35) GSK3AGSK3BCDK1HTTSMN1; SMN2
SCHEMBL2905411 0.86 GSK3B (0.35) GSK3AGSK3BCDK1MAPT
SCHEMBL2903846 0.86 GSK3A (0.41) GSK3AGSK3BCDK1L3MBTL1CYP19A1
SCHEMBL2904160 0.86 GSK3A (0.41) GSK3AGSK3BCDK1L3MBTL1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed